Cord Blood America Inc. (OTC:CBAI) Top Traded OTC

In BUSINESS OF STEM CELLS on August 26, 2009 at 6:02 pm

Cord Blood America Inc. (OTC:CBAI) Is The Top Traded OTC Stock

stemcells_money1HARD TO TREAT DISEASES (PINK:HTDS) and Universal Detection Technology (OTC:UNDT) Round Out Top Three Volume Gainers During Morning Trading Hours

Dallas, TX 8/13/2009 02:35 PM GMT (TransWorldNews)

Dallas, TX – Penny Stock Pick Alert is a penny stock newsletter that is pleased to alert investors of top stocks on the move.

Cord Blood America Inc. (OTC:CBAI) is up 3% to $0.0032 on huge volume of 4.50 million shares within first hour of trade. On August 11, 2009, Cord Blood America, Inc. (OTC Bulletin Board: CBAI), one of the largest umbilical cord blood stem cell preservation companies focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced that work has begun at its new, 17,000 square foot facility in Las Vegas for conversion into a state-of-the-art laboratory for the storage of stem cells and for research and development.

HARD TO TREAT DISEASES (PINK:HTDS) is also moving higher by 23% at $0.0163 on very unusual volume of 92 million shares . Yesterday August 12, 2009 Hard to Treat Diseases, Inc. (HTDS:PK), announced that Hard To Treat Diseases (HTDS.PK) Completes IP Ownership Filings With U.S. Patent and Trademark Office.

via Cord Blood America Inc. (OTC:CBAI) Is The Top Traded OTC.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: